Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553447 · ClinicalTrials.gov registry record · NA
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT02553447 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 197 participants.
The verdict
NCT02553447, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
This randomized pilot early phase I trial studies how well cholecalciferol works in treating patients with newly diagnosed non-Hodgkin lymphoma or chronic lymphocytic leukemia with low levels of vitamin D (vitamin D deficiency). Cholecalciferol may increase levels of vitamin D and improve survival in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia receiving standard of care chemotherapy.
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2015-10-19 |
| Est. Completion | 2025-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02553447
The ClinicalTrials.gov registry entry for NCT02553447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT02553447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02553447 about?
NCT02553447 is a clinical study titled "Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency". This randomized pilot early phase I trial studies how well cholecalciferol works in treating patients with newly diagnosed non-Hodgkin lymphoma or chronic lymphocytic leukemia with low levels of vitamin D (vitamin D deficiency). Cholecalciferol may increase levels of vitamin D and improve survival i...
What is the current status of trial NCT02553447?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2015-10-19. Estimated completion is 2025-04-12.
What interventions are being tested in trial NCT02553447?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT02553447?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.